Citadel Advisors
DOVA

Citadel Advisors’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

Citadel Advisors’s Portfolio DOVA Stock Details DOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-21,700
Closed -$306K – 10114
2019
Q2 		$306K Buy
+21,700
New +$206K ﹤0.01% 7560

Citadel Advisors's DOVA Position: Q4 2019 in Review

Citadel Advisors sold out of Dova Pharmaceuticals, Inc. Common Stock (DOVA) in Q4 2019, closing a stake of 7,214 shares — an estimated $202K sold.

Citadel Advisors first reported a position in DOVA in Q2 2018 and held it in 5 quarters. The position peaked at $1.73M in Q2 2019. 0 funds tracked by Wall St. Rank hold DOVA as of Q4 2019.

  • Citadel Advisors reported no remaining Dova Pharmaceuticals, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Citadel Advisors sold 7,214 Dova Pharmaceuticals, Inc. Common Stock shares in Q4 2019, an estimated $202K.
  • Citadel Advisors first reported a position in Dova Pharmaceuticals, Inc. Common Stock in Q2 2018 and held it in 5 quarters.
  • Citadel Advisors's Dova Pharmaceuticals, Inc. Common Stock position peaked at $1.73M in Q2 2019.
  • 0 funds tracked by Wall St. Rank held Dova Pharmaceuticals, Inc. Common Stock as of Q4 2019.

Based on Citadel Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.